Saurabh M Mishra

About

Dr. Saurabh M Mishra is currently working as Scientist-1 in Formulation and Process Development department of Bausch Health Inc, based in Petaluma, California. Before joining Bausch Health he worked as Formulation scientist and Manager of Pharmaceutical Application Laboratory of SE Tylose USA Inc (ShinEtsu Chemicals, LTD) based in Totowa, NJ. He earned his master's (M.S) and PhD in Industrial Pharmacy from St. John's University, New York, USA. He carries out research in Powder Technology, Continuous Manufacturing, Solid dispersions and Controlled Release Formulations.

Employment

• Bausch Health Scientist-1
  2022 - Present
• SE Tylose USA Inc Manager/Scientist
  2019 - 2022
• Saint John's University Doctoral Fellow
  2015 - 2019

Education

• Saint John's University PhD
  2015 - 2019

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Downstream Processing of Itraconazole:HPMCAS Amorphous Solid Dispersion: From Hot-Melt Extrudate to Tablet Using a Quality by Design Approach
  Pharmaceutics 2022 DOI: 10.3390/pharmaceutics14071429
  +Save
• Effect of Physical Properties and Chemical Substitution of Excipient on Compaction and Disintegration Behavior of Tablet: A Case Study of Low-Substituted Hydroxypropyl Cellulose (L-HPC)
  Macromol 2022 DOI: 10.3390/macromol2010007
  +Save
• Downstream processing of spray-dried ASD with hypromellose acetate succinate – Roller compaction and subsequent compression into high ASD load tablets
  International Journal of Pharmaceutics: X 2021 DOI: 10.1016/j.ijpx.2021.100099
  +Save
• Application of modified SeDeM expert diagram system for selection of direct compression excipient for liquisolid formulation of Neusilin® US2
  Journal of Drug Delivery Science and Technology 2021 DOI: 10.1016/j.jddst.2021.102506
  +Save
• Process optimization of twin-screw melt granulation of fenofibrate using design of experiment (DoE)
  International Journal of Pharmaceutics 2021 DOI: 10.1016/j.ijpharm.2020.120101
  +Save
• Determination of maximum flowable liquid-loading potential of Neusilin® US2 and investigation of compressibility and compactibility of its liquisolid blends with PEG (400)
  Journal of Drug Delivery Science and Technology 2019 DOI: 10.1016/j.jddst.2019.101285
  +Save
• Mechanics of tablet formation: a comparative evaluation of percolation theory with classical concepts
  Pharmaceutical Development and Technology 2019 DOI: 10.1080/10837450.2019.1599913
  +Save
• Application of 3D printing technology and quality by design approach for development of age-appropriate pediatric formulation of baclofen
  International Journal of Pharmaceutics 2019 DOI: 10.1016/j.ijpharm.2018.11.062
  +Save
• An integrated, quality by design (QbD) approach for design, development and optimization of orally disintegrating tablet formulation of carbamazepine
  Pharmaceutical Development and Technology 2017 DOI: 10.1080/10837450.2016.1199566
  +Save